Azicin (azithromycin) coated tablets 0.5 g. N3

$14.10

Manufacturer: Ukraine

Purpose: Azithromycin inhibits bacterial growth to treat infections such as respiratory tract infections.

SKU: MED56730 Category:

Description

Azicin (azithromycin) Coated Tablets 0.5 g. N3

Ingredients

Each coated tablet contains 0.5 g of azithromycin.

Dosage

The usual dosage is one tablet (0.5 g) once a day. Take as directed by your healthcare provider.

Indications

Azicin tablets are indicated for the treatment of bacterial infections. It is commonly used to treat respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.

Contraindications

Do not take Azicin if you are allergic to azithromycin or other macrolide antibiotics. Consult your doctor before use if you have liver or kidney disease.

Directions

Swallow the tablet whole with a full glass of water. It can be taken with or without food. Follow the prescribed dosage and duration of treatment.

Scientific Evidence

Azithromycin, the active ingredient in Azicin tablets, has been extensively studied for its efficacy in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy has shown azithromycin to be effective against a wide range of pathogens, making it a valuable antibiotic in clinical practice.

Additional Information

It is important to complete the full course of Azicin tablets as prescribed by your healthcare provider, even if you start to feel better before the treatment is finished. This helps prevent the development of antibiotic resistance. If you experience severe or persistent side effects, contact your doctor immediately.

Pharmacological Effects: Azithromycin works by inhibiting bacterial protein synthesis, thereby preventing the growth and spread of bacteria in the body. It is particularly effective against respiratory pathogens and is well-absorbed when taken orally.

Clinical Trials: Clinical trials have demonstrated the efficacy of azithromycin in treating respiratory infections, including community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease. Compared to other antibiotics, azithromycin has shown comparable or superior effectiveness with a favorable safety profile.